{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:33:10Z","timestamp":1790631190161,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.tracli.2021.01.013","type":"journal-article","created":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T11:48:21Z","timestamp":1611748101000},"page":"143-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Transfusion and sickle cell anemia in Africa"],"prefix":"10.1016","volume":"28","author":[{"given":"S.","family":"Diop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Pirenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2021.01.013_bib0150","doi-asserted-by":"crossref","first-page":"18010","DOI":"10.1038\/nrdp.2018.10","article-title":"Sickle cell disease","volume":"4","author":"Kato","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.tracli.2021.01.013_bib0155","doi-asserted-by":"crossref","first-page":"e393","DOI":"10.1016\/S2352-3026(19)30111-5","article-title":"Sickle cell disease: a new era","volume":"6","author":"Simpson","year":"2019","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.tracli.2021.01.013_bib0160","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ncomms1104","article-title":"Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis","volume":"1","author":"Piel","year":"2010","journal-title":"Nat Commun"},{"key":"10.1016\/j.tracli.2021.01.013_bib0165","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/bjh.14383","article-title":"Guidelines on red cell transfusion in sickle cell disease part II: indications for transfusion","volume":"176","author":"Davis","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tracli.2021.01.013_bib0170","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1053\/j.seminhematol.2020.07.007","article-title":"Transfusion support in patients with Sickle cell disease","volume":"57","author":"Sharma","year":"2020","journal-title":"Semin Hematol"},{"key":"10.1016\/j.tracli.2021.01.013_bib0175","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/vox.12705","article-title":"Blood transfusion in sub-Saharan Africa: understanding the missing gap and responding to present and future challenges","volume":"113","author":"Barro","year":"2018","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2021.01.013_bib0180","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","article-title":"Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates","volume":"381","author":"Piel","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.tracli.2021.01.013_bib0185","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ajh.24986","article-title":"The clinical epidemiology of sickle cell anemia in Africa","volume":"93","author":"Macharia","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tracli.2021.01.013_bib0190","doi-asserted-by":"crossref","first-page":"e1001484","DOI":"10.1371\/journal.pmed.1001484","article-title":"Global burden of sickle cell anaemia in children under five, 2010\u20132050: modelling based on demographics, excess mortality, and interventions","volume":"10","author":"Piel","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.tracli.2021.01.013_bib0195","doi-asserted-by":"crossref","first-page":"e503","DOI":"10.1016\/S2352-3026(20)30180-0","article-title":"Screening infants for sickle cell disease in sub-Saharan Africa: starting the journey to a sustainable model in primary care","volume":"7","author":"Streetly","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.tracli.2021.01.013_bib0200","first-page":"95","article-title":"Towards an information system for sickle cell neonatal screening in Senegal","volume":"258","author":"Diallo","year":"2019","journal-title":"Stud Health Technol Inform"},{"key":"10.1016\/j.tracli.2021.01.013_bib0205","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bcmd.2019.01.007","article-title":"HemoTypeSC, a low-cost point-of-care testing device for sickle cell disease: promises and challenges","volume":"78","author":"Nnodu","year":"2019","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.tracli.2021.01.013_bib0210","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/03630269.2017.1329151","article-title":"Preliminary evaluation of a point-of-care testing device (SickleSCAN\u2122) in screening for sickle cell disease","volume":"41","author":"Nwegbu","year":"2017","journal-title":"Hemoglobin"},{"key":"10.1016\/j.tracli.2021.01.013_bib0215","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1182\/bloodadvances.2019001143","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support","volume":"4","author":"Chou","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.tracli.2021.01.013_bib0220","article-title":"Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews","volume":"8","author":"Fortin","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tracli.2021.01.013_bib0225","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/trf.13558","article-title":"Effectiveness of red blood cell exchange, partial manual exchange, and simple transfusion concurrently with iron chelation therapy in reducing iron overload in chronically transfused sickle cell anemia patients","volume":"56","author":"Fasano","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.01.013_bib0230","first-page":"402","article-title":"Evaluation of transfusion practices in sickle cell disease in Senegal: cohort study of 1078 patients with sickle cell disease","volume":"27","author":"Seck","year":"2017","journal-title":"Med Sante Trop"},{"key":"10.1016\/j.tracli.2021.01.013_bib0235","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s12098-007-0129-4","article-title":"Blood transfusion rate in Congolese patients with sickle cell anemia","volume":"74","author":"Tshilolo","year":"2007","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.tracli.2021.01.013_bib0240","doi-asserted-by":"crossref","first-page":"3518402","DOI":"10.1155\/2017\/3518402","article-title":"Efficacy and safety of manual partial red cell exchange in the management of severe complications of sickle cell disease in a developing country","volume":"2017","author":"Faye","year":"2017","journal-title":"Adv Hematol"},{"key":"10.1016\/j.tracli.2021.01.013_bib0245","first-page":"387","article-title":"Effectiveness, safety, and cost of partial exchange transfusions in patients with sickle cell anemia at a sickle cell disease center in sub-Saharan Africa","volume":"27","author":"Boma Muteb","year":"2017","journal-title":"Med Sante Trop"},{"key":"10.1016\/j.tracli.2021.01.013_bib0250","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/inthealth\/ihw014","article-title":"Blood transfusion services for patients with sickle cell disease in Nigeria","volume":"8","author":"Diaku-Akinwumi","year":"2016","journal-title":"Int Health"},{"key":"10.1016\/j.tracli.2021.01.013_bib0255","series-title":"Global status report on blood safety and availability 2016","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.tracli.2021.01.013_bib0260","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1537-2995.2010.02886.x","article-title":"Estimate of the residual risk of transfusion-transmitted human immunodeficiency virus infection in sub-Saharan Africa: a multinational collaborative study","volume":"51","author":"Lefr\u00e8re","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.01.013_bib0265","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.tmrv.2019.06.003","article-title":"Red blood cell allo-immunization in transfused patients with sickle cell disease in Sub-Saharan Africa; a systematic review and meta-analysis","volume":"33","author":"Boateng","year":"2019","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tracli.2021.01.013_bib0270","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2018-02-785964","article-title":"How I safely transfuse patients with sickle cell disease and manage delayed hemolytic transfusion reactions","volume":"131","author":"Pirenne","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2021.01.013_bib0275","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.crvi.2012.09.010","article-title":"Post-transfusional iron overload in the haemoglobinopathies","volume":"336","author":"Thuret","year":"2013","journal-title":"C R Biol"},{"key":"10.1016\/j.tracli.2021.01.013_bib0280","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/vox.12702","article-title":"The Francophone Africa Network or Transfusion Medicine Research. Updated characteristics of Blood services, donors and blood products in 11 French-Speking African countries","volume":"113","author":"Tagny","year":"2018","journal-title":"Vox Sanguinis"},{"key":"10.1016\/j.tracli.2021.01.013_bib0285","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/voxs.12226","article-title":"Sickle cell disease in sub-Saharan Africa","volume":"11","author":"Moubouossie","year":"2016","journal-title":"ISBT Sci Series"},{"key":"10.1016\/j.tracli.2021.01.013_bib0290","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1182\/bloodadvances.2017GS102211","article-title":"The CADRE (C\u0153ur Art\u00e8res et DREpanocytose [Heart Arteries and Sickle Cell Disease]) study","volume":"1","author":"Diop","year":"2017","journal-title":"Blood Adv"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782021000318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782021000318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:39:03Z","timestamp":1761129543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782021000318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1246782021000318"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2021.01.013","relation":{},"ISSN":["1246-7820"],"issn-type":[{"value":"1246-7820","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transfusion and sickle cell anemia in Africa","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2021.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 fran\u00e7aise de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}